Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Nov;12(6):403-7.
doi: 10.2188/jea.12.403.

Incidence of Parkinson disease in Wakayama, Japan

Affiliations

Incidence of Parkinson disease in Wakayama, Japan

Seiji Morioka et al. J Epidemiol. 2002 Nov.

Abstract

To estimate an accurate annual incidence of Parkinson disease in Wakayama, a mail survey was conducted in 1998. A questionnaire was delivered to each clinic where Parkinson disease would be potentially diagnosed. The survey was conducted in February 1998 by the Research Committee on Parkinson disease of Wakayama. A total of 792 clinics and 87 hospitals were listed as candidates. Physicians in these 879 medical facilities were asked and instructed to register all newly diagnosed patients with Parkinson disease in 1997 according to the diagnostic criteria proposed by the Japanese Research Committee on Neuro-degenerative Diseases. Of 879 facilities, 873 ones including 81 hospitals replied (response rate: 99%). A total of 229 patients were reported as newly diagnosed cases in 1997. Of these cases, 183 cases were classified as Yahr I to III. The annual incidence rate was 16.9 per 100,000 population (95% confidence interval: 14.5-19.3). Male-to-female ratio was 1:1.4 as a whole, and the dominant age stratum was 70 to 79 years old. When Parkinson disease incidence was observed from northern part of Wakayama to south by district, crude rates (95% CIs) were 15.9(12.9-18.9), 18.1(12.0-24.2), and 19.3(13.4-25.2). After age-adjustment using the Japanese Model Population in 1985, differences of Parkinson disease incidence became attenuated and adjusted rates (95% CIs) turned to 10.8(9.1-12.7), 10.4(8.6-12.2), and 9.9(6.9-12.9), respectively.

PubMed Disclaimer

References

    1. Ohno Y, Kawamura T, Tamakoshi A, Wakai K, Aoki R, Kojima M, et al. . Epidemiology of diseases of unknown etiology specified as “intractable diseases”. J Epidemiol 1996;6(Suppl):S87-94. - PubMed
    1. Marttila RJ, Rinne UK. Disability and progression in Parkinson’s disease. Acta Neurol Scand 1977;56:159-69. - PubMed
    1. Kasamatsu T, Hashimoto T. Epidemiology of intractable diseases in Wakayama, Japan. In ; Aoki K ed. Annual report of the research committee on intractable diseases in Japan in 1986. Tokyo,1986:289-296. (in Japanese)
    1. Ben-Shlomo Y. Parkinson’s disease. In ; Martyn CN, Hughes RAC, eds. The epidemiology of neurological disorders, 1st ed. BMJ Books, London, 1998:1-33.
    1. Morioka S, Sakata S, Yasuda Y, Hashimoto T, Yoshida S, Nakai E, et al. A trial for Parkinson disease registry in Wakayama. In ; Ohno Y ed. Annual report of the research committee on intractable diseases in Japan in 1998. Tokyo,1998:73-77. (in Japanese)

Publication types